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Abstract
Objectives: To compare scores on the 36- item WHO Disability Assessment Schedule 
2.0 tool (WHODAS- 36) for postpartum women across a continuum of morbidity and 
to validate the 12- item version (WHODAS- 12).
Methods: This is a secondary analysis of the Brazilian retrospective cohort study on 
long- term repercussions of severe maternal morbidity. We determined mean, median, 
and percentile values for WHODAS- 36 total score and for each domain, and percen-
tile values for WHODAS- 12 total score in postpartum women divided into three 
groups: “no,” “nonsevere,” and “severe” morbidities.
Results: The WHODAS- 36 mean total scores were 11.58, 18.31, and 19.19, respec-
tively for no, nonsevere, and severe morbidity. There was a dose- dependent effect on 
scores for each domain of WHODAS- 36 according to the presence and severity of 
morbidity. The diagnostic validity of WHODAS- 12 was determined by comparing it 
with WHODAS- 36 as a “gold standard.” The best cut- off point for diagnosing dysfunc-
tionality was the 95th percentile.
Conclusion: The upward trend of WHODAS- 36 total mean value scores of women 
with no morbidity compared with those with morbidity along a severity continuum 
may reflect the impact of morbidity on postpartum functioning.
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1  | INTRODUCTION
Progress in maternal health and the consequent reduction in maternal 
mortality are considered important goals worldwide, as part of the fifth 
Millennium Development Goal and, presently, of the third Sustainable 
Development Goal.1,2 Since the 1990s, there has been significant 
improvement in maternal and perinatal health indicators, with a decline 
of about 50% in the overall maternal mortality rate.3 Improvements in 
antenatal care,4 as well as access to institutional deliveries, using clean 
delivery kits,5 and interventions to prevent and manage hypertensive 
disorders and postpartum hemorrhage6,7 have likely contributed to 
that reduction. However, there are still many challenges to ascertain 
women’s health and well- being during pregnancy and the postpartum 
period, even among those women with no medical complications, 
especially in low- and middle- income countries.
The postpartum period is characterized by multiple concerns 
involving self- confidence, mother–infant interaction, body image 
experiences, adjustment to maternal roles, and attitudes.8 These con-
cerns—which are not only dependent on the presence or diagnosis of 
morbidity, but also on the inadequate assessment of such issues or 
even their misinterpretation—may contribute to the deterioration of 
maternal and newborn health.9
The occurrence of severe maternal morbidity (SMM), defined as 
having a potentially life- threatening condition (PLTC) and/or maternal 
near miss (MNM), has been studied over the past decade: impacts on 
maternal and child health are unquestionable,10–12 as are their effects 
on women’s functionality (her ability to perform everyday tasks, includ-
ing social and economic responsibilities).13 Non- life- threatening or 
nonsevere maternal morbidity (non- SMM) is also a theme of concern 
and is currently defined as “any health condition attributed to and/or 
complicating pregnancy and childbirth that has a negative impact on 
the woman’s well- being and/or functioning”.3 However, even among 
new mothers without morbidity, the inherent complexity of pregnancy 
and the postpartum period should be considered when providing care 
to this specific population.
Monitoring more than just the traditional indicators of health, preg-
nancy, and childbirth requires an expanded approach. Information on 
disability and functioning is an important component of health assess-
ment and has provided helpful evidence for measuring disease burden 
across different settings,14,15 through a tool developed by the WHO 
called the WHO Disability Assessment Schedule 2.0 (WHODAS 2.0).16 
This tool seeks to measure functionality, and considers six domains 
(cognition, mobility, self- care, getting along with people, life activities, 
and participation) as they apply to daily living activities in the 30 days 
preceding the tool’s application. The complete version has 36 ques-
tions (WHODAS- 36), while a shorter 12- item version is also available 
(WHODAS- 12). However, the WHODAS has not often been applied to 
women of reproductive age, during pregnancy, or the postpartum period.
To better understand WHODAS scores, and their distribution, 
among postpartum women, with the intention of suggesting a cut- off 
point for screening, we applied this instrument to women with no mor-
bidity and those on a continuum of morbidity (any morbidity to SMM). 
We further validated the shorter WHODAS- 12 using the full 36- item 
version as a reference for the assessment of disability and functioning 
in nonmorbid postpartum women.
2  | MATERIALS AND METHODS
This is a secondary analysis of the Brazilian Cohort on Severe Maternal 
Morbidity (COMMAG)—a retrospective cohort study that included 
women who delivered between July 1, 2008, and June 30, 2012, at 
the Women’s Hospital of the University of Campinas, Brazil. The study 
was a long- term evaluation of the consequences of PLTC and MNM 
incidents using a multidimensional approach.17 The details of the 
methods used for the main study and primary results on WHODAS 
have been published elsewhere.13,18 Briefly, cases of SMM were iden-
tified using the standardized WHO criteria,19 as PLTC and MNM, and 
compared with a randomly selected control group, without SMM. One 
of the instruments used to assess women’s functioning status was the 
WHODAS 2.0 (for both cases and controls). Participants provided 
informed consent and the University of Campinas institutional review 
board provided approval for the original study.
For the current analysis, we aimed to select, from among the con-
trol group, all cases with no morbidity at all (during gestation, delivery, 
or postpartum). This involved applying the broad WHO definition for 
and criteria of maternal morbidity.3 Cases with any previous medical 
condition (hypertension, diabetes, anemia, cardiovascular disease, 
autoimmune disease, smoking, etc.) and cases with any complications 
documented during any pregnancy (pre- eclampsia, hemorrhage, and 
infection, among others) were excluded from the no morbidity group. 
It is relevant to consider that our study included evaluations/inter-
views with women any time from 1 to 5 years postpartum and partici-
pants could have had other pregnancies during the intervening period. 
We hypothesized that any complication could impact the woman’s 
WHODAS score. Considering this approach, we were able to identify 
three groups: SMM, non- SMM, and no morbidity. We performed our 
analyses using these three groups. We used a virtual database built for 
the main study using the LimeSurvey platform (www.limesurvey.org; 
LimeSurvey GmbH, Hamburg, Germany).
Our group translated the instrument into Brazilian Portuguese.13 
The total score for WHODAS ranges from 0–100, where a high score 
indicates major living limitations.16 The shorter WHODAS- 12 consists 
of two questions from each domain (called sentinel key questions) 
of the full 36- item version of the WHODAS.16 A trained interviewer 
administered the WHODAS- 36 questionnaire (which only includes 32 
questions if the participant is unemployed and no longer in school).
Sociodemographic, obstetric, and perinatal characteristics were 
described for each group considered. We determined mean, median, 
and percentile values for WHODAS- 36 total score, and separately for 
each domain. For each domain we excluded cases with missing data in 
any question. We also determined percentile values for WHODAS- 12 
total score. For the short version, the detailed analysis on domains is 
not possible.16 The results were compared using the Kruskal- Wallis 
test between groups. A P value of 0.05 or below was considered sta-
tistically significant.
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We further validated the WHODAS- 12 (using the WHODAS- 36 
as the “gold standard” for diagnosing disability and measuring func-
tioning) for three percentiles: P90, P95, and P97.5. Finally, the best 
cut- off points for screening accuracy of impaired functioning for both 
WHODAS- 36 and WHODAS- 12 were determined using receiver 
operating characteristic (ROC) curves for each endpoint. Our goal was 
to identify, from our sample, a group of women with no morbidity and 
to study their baseline WHODAS results in comparison with those of 
women presenting with maternal morbidity.
3  | RESULTS
Overall, there were 128 women with no morbidity (Fig. 1). Table 1 
presents the sociodemographic and obstetric characteristics of these 
women as well as their perinatal outcomes. Women were generally 
young (mean age, 28.0 ± 6.4 years), multiparous, non- white, and with 
a partner. The majority of deliveries were vaginal and nonoperative 
(57%), with low rates of prematurity and neonatal deaths.
Considering the three groups of women on a continuum of sever-
ity, the WHODAS- 36 total mean scores were 11.58, 18.31, and 19.19 
for no morbidity, non- SMM, and SMM, respectively (Fig. 2). Table 2 
shows mean and median values for each of the six WHODAS- 36 
domains by morbidity category. For the no morbidity group, domains 
1 (cognition) and 4 (getting along with people) presented the high-
est mean values. Scores for five domains of WHODAS- 36 (all except 
domain 4) were significantly different, generally depicting a dose- 
dependent effect according to the presence and severity of morbidity 
(except for domains 1 and 4). The mean WHODAS scores were higher 
for women with ongoing medical diseases in comparison with those 
without.20 Additionally, we examined the 31 perinatal deaths in the 
sample (29 in the group of maternal morbidity), and found no signifi-
cant impact of perinatal death on general or domain scores.
To evaluate the performance of the 12- item version of the instru-
ment, we compared WHODAS- 36 and WHODAS- 12 total scores 
for the nonmorbid group. Results were very similar (Table 3) when 
F IGURE  1 Flow chart of women included in the study.
???????????????? ???????????????????? ???????????????????????? ???????????????? ???????????????????? ?????? ?????????????? ????????????????????
TABLE  1 Sociodemographic and obstetric characteristics of 
women with no maternal morbidity (n=128).
Characteristics No. (%)
Age, y 28.0 ± 6.4
<20 11 (8.6)
20–29 70 (54.7)
30–39 39 (30.5)
≥40 8 (6.3)
Parity
1 58 (45.3)
≥2 70 (54.7)
Ethnicity
White 57 (44.5)
Non- white 71 (55.5)
Schooling
<8 years 35 (27.3)
≥8 years 92 (72.7)
Relationship status
No partner 22 (17.2)
Partner 106 (82.8)
Mode of delivery
Vaginal 73 (57.0)
Operative vaginal delivery 10 (7.8)
Cesarean 45 (35.2)
Prematurity
Yes 11 (8.6)
No 117 (91.4)
Perinatal outcome
Alive 128 (100.0)
Neonatal outcome
Discharged healthy 124 (96.9)
Early neonatal death (<1 week) 1 (0.8)
Late neonatal death (7–28 days) 1 (0.8)
Missing data 2 (1.6)
F IGURE  2 WHODAS- 36 mean total score in a continuum  
of severity, considering three groups: no morbidity, nonsevere 
maternal morbidity, and severe maternal morbidity. Kruskal- Wallis 
test (P<0.05). [Colour figure can be viewed at wileyonlinelibrary.com]
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analyzed for different percentiles. For the complete WHODAS- 36, we 
were able to further analyze scores by domain: women scored highest 
(i.e. had a reduced functioning status) in domains 1 (cognition), 4 (get-
ting along with people), and 5 (life activities).
We tested three possible cut- off points that could have clinical rel-
evance in evaluating WHODAS scores: percentiles 90, 95, and 97.5 
were considered (Table 4). The best cut- off point to diagnose signifi-
cantly reduced function among postpartum women without any mor-
bidity or complication was the 95th percentile, with the largest area 
under the curve of 0.996 (Fig. 3).
4  | DISCUSSION
Given that, as a result of successful efforts to decrease maternal 
mortality, more women than ever are now surviving childbirth, and 
that well- being is understood as a broad spectrum, it is relevant to 
understand women’s functioning during pregnancy and the postpar-
tum period, and the impact of morbidities in causing reduced function. 
It is important to document standard values of WHODAS scores, in 
women of reproductive age and in the postpartum period, in order 
to study the impact of pregnancy and related maternal morbidity 
on functioning and disability. The present study gives the total and 
domain scores for WHODAS- 36 in a population with no morbidity 
at all, compared with scores from women on a continuum of sever-
ity (non- SMM and SMM). To the best of our knowledge, this is the 
first study to establish baseline WHODAS scores among postpartum 
women without morbidity.
The WHODAS 2.0 tool was developed to assess difficulties due 
to health conditions, without distinguishing whether the disability is 
mental or physical in origin21; rather it presents a correlation between 
injury and disability. When WHODAS 2.0 is applied to postpartum 
women without morbidity, instead of an injury, the intended cor-
relation is between the complex factors present in the woman’s life 
at the time (involving both physical and emotional changes due to 
pregnancy, childbirth, and childcare, characterized by concerns about 
self- confidence, stress over physical attractiveness, mental and social 
vulnerabilities) and their effects on her everyday functioning.22
Although WHODAS does not measure well- being,23 the scores 
are strongly influenced by this concept, which itself depends on soci-
ety, culture, and an individual’s references. For instance, in Shanghai, 
China, a recently published study shows that maternal satisfaction 
and postpartum well- being were correlated with giving birth to male 
infants, and the preference for male children has been well described 
in Chinese culture.24 Cultural diversity determines conceptual diver-
sity of well- being and this may influence WHODAS score as well.
The increasing trend of WHODAS- 36 total score mean value 
across the three groups analyzed (without morbidity, non- SMM, and 
SMM) may reflect the impact of complications on the new mother. 
Our analysis suggests that regardless of type, complications influence 
a woman’s perception of her functionality, which correlates with the 
magnitude of the complication. Otherwise, the differences between 
the mean scores across the three groups would be larger. Recognizing 
this is important for establishing the care pathways destined for these 
women during and after the adverse outcomes, especially for the 
group classified as having non- SMM.
Postpartum period functionality is the result of a sum of factors 
reflected by the WHODAS score. The six domains analyzed reflect 
general areas of life16 and the mean values found in our study may 
reveal the complexity of the postpartum period and conditions that 
sometimes go unnoticed by the woman and/or her clinician. The two 
domains that contributed the most to WHODAS- 36 total score mean 
value (11.58) among women without medical complications were 
domains 1 (cognition) and 4 (getting along with people). Domain 1 
TABLE  2 WHODAS- 36 total score and specific domain values presented as mean, median, and standard deviation, for the three groups, no 
morbidity, nonsevere maternal morbidity, and severe maternal morbidity.
Statistics
Women with no morbidity Women with non- SMM Women with SMM
P valueaMeanb Medianb SD Meanb Medianb SD Meanb Medianb SD
Total score 11.6 7.6 11.6 18.3 14.1 15.6 19.2 15.1 16.5 <0.001
Domain 1c 17.9 15.0 16.3 23.8 20.0 18.8 21.4 20.0 18.3 0.022
Domain 2 8.1 0.0 13.4 13.9 6.3 19.4 16.0 6.3 20.2 <0.001
Domain 3 2.4 0.0 6.3 5.9 0.0 13.1 6.2 0.0 13.5 0.028
Domain 4 13.9 8.3 20.4 14.9 8.3 19.6 14.6 8.3 20.6 0.478
Domain 5 11.8 0.0 18.1 22.8 10.0 26.7 26.1 12.5 28.8 <0.001
Domain 6 10.8 4.2 14.7 21.5 16.7 20.6 23.5 20.8 21.7 <0.001
Abbreviations: SD, standard deviation; non- SMM, nonsevere maternal morbidity; SMM, severe maternal morbidity.
aKruskal- Wallis test (P<0.05).
bRange values of mean/median: 0–100.
cDomain 1: cognition (assesses communication and thinking activities); Domain 2: mobility (assesses activities such as standing, moving around inside the 
home, getting out of the home, and walking a long distance); Domain 3: self- care (assesses bathing, dressing, eating, and staying alone); Domain 4: getting 
along with people (assesses interactions with other people and difficulties found due to a health condition); Domain 5: life activities (assesses difficulties in 
activities of daily life, associated with household chores, leisure time, work, and school); Domain 6: participation (assesses social dimensions, such as com-
munity activities, barriers and hindrances in the world around individual, and other problems such as personal dignity maintenance).
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includes questions about memory, learning new tasks, and problem 
solving in daily life, factors that are correlated to the woman’s need 
to recognize herself within a new family context with a new role (that 
of mother), in addition to experiencing the bodily changes associ-
ated with pregnancy and the expectation of having to deal with the 
unknown. Domain 4 questions include difficulties related to sexual 
activities during the last 30 days. The majority of new mothers resume 
intercourse within the first 3 months after an uncomplicated preg-
nancy and the vast majority of women experience at least one problem 
related to sexual function in the first year after delivery.25
On the other hand, when comparing across the three groups, 
Domain 4 scores remained constant. This is in agreement with the 
findings of Andreucci et al.,12 who applied the Female Sexual Function 
TABLE  3 Values of percentiles 90, 95, and 97.5 for WHODAS- 36 
total and domain scores, and for WHODAS- 12 total scores, among 
women with no morbidity (n=127a).
Percentiles by WHODAS- 36 domains and total 
scores (for WHODAS- 36 and - 12) Score (95% CI)
Domain 1: Cognition
Percentile 90 45.0 (40.0–50.0)
Percentile 95 50.0 (45.0–57.8)
Percentile 97.5 55.0 (50.0–65.0)
Domain 2: Mobility
Percentile 90 31.3 (18.8–43.8)
Percentile 95 43.8 (31.3–47.2)
Percentile 97.5 43.8 (43.8–56.3)
Domain 3: Self- care
Percentile 90 10.0 (10.0–13.2)
Percentile 95 17.0 (10.0–25.6)
Percentile 97.5 20.0 (11.2–40.0)
Domain 4: Getting along with people
Percentile 90 50.0 (33.3–58.3)
Percentile 95 58.3 (50.0–83.3)
Percentile 97.5 81.5 (58.3–83.3)
Domain 5: Life activities
Percentile 90 40.0 (30.0–50.0)
Percentile 95 50.0 (40.0–66.9)
Percentile 97.5 62.0 (47.5–83.3)
Domain 6: Participation
Percentile 90 29.6 (25.0–42.8)
Percentile 95 44.5 (32.7–58.5)
Percentile 97.5 53.2 (42.1–75.0)
Total score (WHODAS- 36)
Percentile 90 30.2 (21.7–38.0)
Percentile 95 38.7 (30.4–48.2)
Percentile 97.5 46.3 (35.5–50.9)
Total score (WHODAS- 12)
Percentile 90 30.9 (23.3–36.1)
Percentile 95 37.4 (32.3–44.1)
Percentile 97.5 43.3 (35.6–50.0)
aOne woman was excluded from this analysis because there was one 
 missing response for Domain 5.
FIGURE 3 Receiver operating characteristic curve for diagnostic 
validity of percentile 95 of WHODAS- 12 compared with WHODAS- 36 
as “gold standard” to determine dysfunction and disability among women 
in the postpartum period. Abbreviations: AUC, area under the curve; 
P, percentile. [Colour figure can be viewed at wileyonlinelibrary.com]
TABLE  4 Diagnostic validity of WHODAS- 12 using WHODAS- 36 
as a “gold standard” to determine dysfunction and disability among 
women in the postpartum period.
P>90 P>95 P>97.5
Sensitivity 83.3% 83.3% 66.7%
Specificity 98.3% 99.2% 99.2%
Positive predictive value 83.3% 83.3% 66.67%
Negative predictive value 98.3% 99.2% 99.2%
AUC ROC 0.976 0.996 0.989
Number of women scoring in  
each category
Percentiles
WHODAS- 36 as 
“gold standard”
P>90 P≤90
WHODAS- 12 as test P>90 10 2
P≤90 2 113
Total 12 115
P>95 P≤95
WHODAS- 12 as test P>95 5 1
P≤95 1 120
Total 6 121
P>97.5 P≤97.5
WHODAS- 12 as test P>97.5 2 1
P≤97.5 1 123
Total 3 124
Abbreviations: AUC, area under the curve; P, percentile; ROC, receiver 
operating characteristic.
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Index to a Brazilian cohort of women with and without SMM, and 
found similar mean scores in the population studied.12 These issues 
may be inherent to the pregnancy and postpartum period regardless 
of the presence or absence of any morbidity.
The WHODAS 12- item version also provides a brief and valuable 
measure of disability among postpartum women. Even though the 
95th percentile of total mean scores had the largest area under the 
curve, we hypothesize that the best value for applying WHODAS- 12 
as a screening test for diagnosing disability is the 90th percentile, 
given that the lowest specificity value is required for screening tests 
and this would allow identification of more women as having some 
kind of functional impairment, regardless of diagnosis (no morbidity, 
non- SMM or SMM). Considering that low- and middle- income coun-
tries have limited resources, the WHODAS- 12 item version could be a 
useful tool, initially for epidemiologic and clinical research, and poten-
tially for becoming a routine screening test for functioning and disabil-
ity in pregnancy and the postpartum period.
At a time when global efforts to improve maternal health have 
been prioritized, a baseline WHODAS score among postpartum 
women without any morbidity is helpful to understand the burden of 
pregnancy and morbidities overall. It could also help guide strategies 
to improve antenatal and postpartum care, as well as other studies 
focusing on specific postpartum conditions.
The increasing WHODAS- 36 mean scores when comparing a 
population of postpartum women with no morbidity with those on a 
continuum of severity may reflect the impact of morbidity on postpar-
tum functioning. The diagnostic validity of the WHODAS- 12 means 
that this brief tool could provide a quick and valuable measurement 
of impaired functioning among postpartum women. The best cut- off 
point to diagnose impaired functioning was the 95th percentile, with 
the largest area under the curve.
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